Pacira BioSciences, Inc. filed post-effective amendments to thirteen Form S-8 registration statements on November 17, 2026, deregistering all remaining unsold shares across equity compensation plans following its merger with Viatris Inc.

Key Highlights

  • Thirteen registration statements terminated: Post-effective amendments were filed to deregister shares under registration numbers 333-175101 through 333-297971.
  • Merger completed November 17, 2026: Peach Purchaser Sub Inc., a wholly owned subsidiary of Viatris Inc., merged with and into Pacira BioSciences, with Pacira surviving as a wholly owned subsidiary of Viatris.
  • Merger Agreement dated October 8, 2026: The transaction was governed by an Agreement and Plan of Merger among Pacira BioSciences, Viatris Inc., and Peach Purchaser Sub Inc.
  • All share offerings terminated: According to the filing, Pacira "has terminated all offerings and sales pursuant to the Registration Statements."
  • No remaining registered shares: The filing states that after giving effect to the amendments, "there will be no remaining Shares registered by the Company pursuant to the Registration Statements."
  • Plans covered multiple programs: The deregistered shares spanned the 2007 Stock Option/Stock Issuance Plan, the Amended and Restated 2011 Stock Incentive Plan, the Amended and Restated 2014 Employee Stock Purchase Plan, and the Amended and Restated 2014 Inducement Plan.

Pacira BioSciences Closes Equity Plan Registrations Following Viatris Acquisition

Pacira BioSciences, Inc. (NASDAQ:PCRX), a Delaware corporation headquartered at 2000 Sierra Point Parkway, Suite 900, Brisbane, California, filed post-effective amendments on November 17, 2026, to terminate thirteen Form S-8 registration statements that had covered employee and director equity compensation plans. The company had registered shares under these plans beginning as early as June 23, 2011, with the most recent registration, No. 333-297971, filed on August 4, 2026, covering 800,000 shares under the Amended and Restated 2014 Employee Stock Purchase Plan.

According to the filing, the action was triggered by the completion of a merger in which Peach Purchaser Sub Inc., a wholly owned subsidiary of Viatris Inc., merged with and into Pacira BioSciences, leaving Pacira as a wholly owned subsidiary of Viatris. The Merger Agreement was dated October 8, 2026, and the merger closed on November 17, 2026. Individual registration statements covered share counts ranging from 175,000 shares under the 2014 Inducement Plan to 4,000,000 shares under the Amended and Restated 2011 Stock Incentive Plan, filed June 17, 2016.

The post-effective amendments were signed by Michael Rainerman, President of Pacira BioSciences, in Brisbane, California. The filing noted that the deregistration fulfills undertakings made by Pacira in the original registration statements to remove any unsold shares by post-effective amendment upon termination of the offerings. After giving effect to all thirteen amendments, the company disclosed that no shares remain registered under any of the covered registration statements.

What Was Disclosed

Pacira BioSciences filed thirteen post-effective S-8 amendments on November 17, 2026, to deregister all unsold equity plan shares following the completion of its merger with Viatris Inc., under which Pacira became a wholly owned subsidiary of Viatris.